Segment disclosures

Company overview

AVITA Medical, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

5 dimension combinations 55 retained observations 16 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

AU · Foreign

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:AU;us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-31275000 USD20230223Open filing evidence
2021-07-01 – 2021-12-31136000 USD20230223Open filing evidence
2020-07-01 – 2021-06-30207000 USD20230223Open filing evidence
2021-01-01 – 2021-03-3125000 USD20210513Open filing evidence
2020-07-01 – 2021-03-31158000 USD20210513Open filing evidence
2020-10-01 – 2020-12-3153000 USD20210216Open filing evidence
2020-07-01 – 2020-12-31133000 USD20210216Open filing evidence
2020-07-01 – 2020-09-3080000 USD20201110Open filing evidence
2019-07-01 – 2020-06-30292000 USD20210826Open filing evidence
2020-01-01 – 2020-03-3146000 USD20210513Open filing evidence
2019-07-01 – 2020-03-31217000 USD20210513Open filing evidence
2019-10-01 – 2019-12-31125000 USD20210216Open filing evidence
2019-07-01 – 2019-12-31171000 USD20210216Open filing evidence
2019-07-01 – 2019-09-3046000 USD20201110Open filing evidence
2018-07-01 – 2019-06-30806000 USD20210826Open filing evidence
2017-07-01 – 2018-06-30550000 USD20200827Open filing evidence

GB · Foreign

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:GB;us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-31160000 USD20230223Open filing evidence
2021-07-01 – 2021-12-3156000 USD20230223Open filing evidence
2020-07-01 – 2021-06-3070000 USD20230223Open filing evidence
2021-01-01 – 2021-03-3115000 USD20210513Open filing evidence
2020-07-01 – 2021-03-3155000 USD20210513Open filing evidence
2020-10-01 – 2020-12-3130000 USD20210216Open filing evidence
2020-07-01 – 2020-12-3140000 USD20210216Open filing evidence
2020-07-01 – 2020-09-3010000 USD20201110Open filing evidence
2019-07-01 – 2020-06-30171000 USD20210826Open filing evidence
2020-01-01 – 2020-03-3151000 USD20210513Open filing evidence
2019-07-01 – 2020-03-31160000 USD20210513Open filing evidence
2019-10-01 – 2019-12-3135000 USD20210216Open filing evidence
2019-07-01 – 2019-12-31109000 USD20210216Open filing evidence
2019-07-01 – 2019-09-3074000 USD20201110Open filing evidence
2018-07-01 – 2019-06-30264000 USD20210826Open filing evidence
2017-07-01 – 2018-06-30379000 USD20200827Open filing evidence

JP · Foreign

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:JP;us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-31729000 USD20230223Open filing evidence

Foreign · AU

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember;srt:StatementGeographicalAxis=country:AU
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-3057000 USD20221110Open filing evidence
2022-01-01 – 2022-09-30173000 USD20221110Open filing evidence
2022-04-01 – 2022-06-3029000 USD20220811Open filing evidence
2022-01-01 – 2022-06-30116000 USD20220811Open filing evidence
2022-01-01 – 2022-03-3187000 USD20220512Open filing evidence
2021-07-01 – 2021-09-3066000 USD20221110Open filing evidence
2021-01-01 – 2021-09-30141000 USD20221110Open filing evidence
2021-04-01 – 2021-06-3049000 USD20220811Open filing evidence
2021-01-01 – 2021-06-3074000 USD20220811Open filing evidence
2021-01-01 – 2021-03-3125000 USD20220512Open filing evidence
2020-07-01 – 2020-09-3080000 USD20211108Open filing evidence

Foreign · GB

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rcel:ForeignMember;srt:StatementGeographicalAxis=country:GB
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-3039000 USD20221110Open filing evidence
2022-01-01 – 2022-09-30121000 USD20221110Open filing evidence
2022-04-01 – 2022-06-3028000 USD20220811Open filing evidence
2022-01-01 – 2022-06-3082000 USD20220811Open filing evidence
2022-01-01 – 2022-03-3154000 USD20220512Open filing evidence
2021-07-01 – 2021-09-3030000 USD20221110Open filing evidence
2021-01-01 – 2021-09-3060000 USD20221110Open filing evidence
2021-04-01 – 2021-06-3015000 USD20220811Open filing evidence
2021-01-01 – 2021-06-3030000 USD20220811Open filing evidence
2021-01-01 – 2021-03-3115000 USD20220512Open filing evidence
2020-07-01 – 2020-09-3010000 USD20211108Open filing evidence